Clashes between European Parliament members Victor Negrescu (S&D), Irena Joveva (Renew), and Carlo Ciccioli (ECR) highlighted fundamental disagreements during the SANT Committee meeting on 23 April 2026, centering on the future European Fund, psychosocial risks at work, and patient-centred health research. The debates revealed political cleavages around dedicated versus flexible health funding, the role of EU competencies in workplace psychosocial protections, and preventive approaches focused on organizational measures versus individual vulnerabilities.
Taking place within the Committee on Public Health meeting, the scrutiny of funding architecture and health priorities brought to light contrasting visions: Negrescu advocated for earmarking at least 4% of the European Fund 2028–2034 specifically for health infrastructure and actions, to the tune of about €35 billion, emphasizing measurable policy targets and strengthening health chapters. This echoes earlier debates on 24 March 2026, where MEPs Gualtieri and Silva clashed over EU health policy, with Gualtieri advocating for increased EU regulation and Silva pushing for national sovereignty. By contrast, voices such as Vlad Vasile-Voiculescu (Renew) supported similar numerical ambition but with a broader rationale about resilience and trust, while Gerald Hauser (PfE) questioned the fund’s broad sectoral mergers and criticized cuts impacting agriculture. Piotr Kowalczyk from the European Commission defended the integrated and flexible plans as supportive of territorial needs, aiming to reduce administrative burdens. This aligns with the Commission's consistent stance on health sovereignty, as reiterated by Commissioner Várhelyi on 21 April 2026, clarifying that the EU does not dictate Poland's hospital bed numbers or maternity ward closures.
Regarding psychosocial risks at work, Irena Joveva urged prevention at source through organizational reforms and strong EU enforcement, recognizing stress and burnout as major workplace risks requiring focused action. This stance clashed with Carlo Ciccioli’s call for incorporating worker selection processes to assess psychosocial vulnerabilities, reflecting a tension between collective preventative measures and individual worker screening. Manuela Ripa (EPP) emphasized proportionality and respect for national competences to avoid overburdening SMEs. The debate on psychosocial risks follows Commissioner Lahbib's 13 April 2026 defense of Member States' sovereignty on conscientious objection in health services, underscoring the ongoing tension between EU-level harmonization and national autonomy.
Concrete proposals included Negrescu’s call for a minimum 4% funding quota dedicated explicitly to health, backed by examples of successful hospital projects and health innovation funded by cohesion policies. Joveva put forward regulatory enhancements for psychosocial risk assessments and clarified employer accountability, although the specifics of enforcement mechanisms remain under discussion. Alternatively, Ciccioli’s proposal to introduce worker vulnerability assessments was less detailed on implementation.
In the domain of patient-centred health research, experts from CEPS highlighted fragmentation caused by weak definitions and lack of standardisation, recommending stronger EU governance structures, dedicated funding, and an EU repository of best practices to enable scaling. These insights influenced Renew’s Stine Bosse’s calls for operational EU tools to make patient input actionable. This focus on patient-centred research complements Commissioner von der Leyen's 15 April 2026 push for inclusive NCD healthcare access and her strategic efforts to bridge HIV healthcare gaps post-2016 framework.
the desire for increasing EU-level health funding visibility and earmarking versus maintaining budget flexibility; expanding EU authority on workplace psychosocial risk legislation versus preserving national sovereignty; emphasizing collective organizational prevention against psychosocial harm versus individual vulnerability selection; and strengthening institutional frameworks for patient-centred research governance versus continuing with fragmented implementation.
Stakeholders substantially impacted include EU producers and health infrastructure operators benefiting from earmarked funds; EU consumers and workers standing to gain from improved psychosocial protections and patient-centred care; national authorities balancing supervisory competences with EU regulatory shifts; and EU taxpayers potentially affected by significant budget allocations.
Looking ahead, the European Parliament is poised to deliberate amendments by early May, with implications for shaping the European Fund’s health priorities and subsequent psychosocial risk directives. Further institutional engagement will likely focus on harmonizing member state competences, ensuring proportionate and effective health interventions, and enhancing patient participation frameworks, to reconcile the observed divergences. This meeting sets the stage for nuanced policy-making balancing financial commitments, regulatory reach, and stakeholder protections in EU health strategy advancement.